Calcium, phosphorus and vitamin D disorders in uremia

Contributions to Nephrology

Volumn 149, Issue , 2005, Pages 261-271

  Slatopolsky, Eduardo ^a   Brown, Alex ^a   Dusso, Adriana ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PHOSPHORUS; VITAMIN D;

ANIMAL; HUMAN; HYPERPLASIA; METABOLISM; PARATHYROID DISEASE; PATHOLOGY; REVIEW; SECONDARY HYPERPARATHYROIDISM; UREMIA;

ANIMALS; CALCIUM; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; PARATHYROID DISEASES; PHOSPHORUS; UREMIA; VITAMIN D;

EID: 20544431807     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000085687     Document Type: Article

References (30)

1. Slatopolsky E, Caglar S, Gradowska L, Canterbury JM, Reiss E, Bricker N: On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using a 'proportional reduction' of dietary phosphorus intake. Kidney Int 1972;2:147-151.
2. Rutherford WE, Bordier P, Marie P, Hruska K, Harter H, Greenwalt A, Blondin J, Haddad J, Bricker N, Slatopolsky E: Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. J Clin Invest 1977;60:332-341.
3. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, Macdonald P, Brown AJ: Phosphorus restriction prevents parathyroid cell growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996;97:2534-2540.
4. Portale AA, Booth BE, Halloran BP, Morris RC Jr: Effects of dietary phosphorus on circulating concentrations of 1,25 dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984;73:1580-1589.
5. Lucas PA, Brown RC, Woodhead JS, Coles GA: 1,25 Dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: Effect of simultaneous protein and phosphorus restriction. Clin Nephrol 1986;25:7-10.
6. Lopez-Hilker S, Dusso A, Rapp N, Martin K, Slatopolsky E: Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 1990;259:F432-F437.
7. Almaden Y, Canalejo A, Hernandez A, Ballesteros E, Garcia-Navarro S, Torres A, Rodriguez M: Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 1996;11:970-976.
8. Nielsen PK, Feldt-Rasmussen U, Olgaard K: A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 1996;11:1762-1768.
9. Moallem E, Kilav R, Silver J, Naveh-Many T: RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 1998;273:5253-5259.
10. Naveh-Many T, Rahamimov R, Livni N, Silver J: Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate and vitamin D. J Clin Invest 1995;96:1786-1793.
11. Yi H, Fukagawa M, Yamato H, Kumagai M, Watanabe T, Kurokawa K: Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: Possible direct role of phosphorus. Nephron 1995;70:242-248.
12. Denda M, Finch J, Slatopolsky E: Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 1996;28:596-602.
13. Dusso A, Lu Y, Pavlopoulos T, Naumovich L, Lu Y, Finch J, Brown AJ, Morrissey J. Slatopolsky E: p21 (WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 2001;59:855-865.
14. Tatsumi S, Segawa H, Morita K, Haga H, Kouda T, Yamamoto H, Inoue Y, Nii T, Katai K, Taketani Y, Miyamoto KI, Takeda E: Molecular cloning and hormonal regulation of PiT-1, a sodium-dependent phosphate cotransporter from rat parathyroid glands. Endocrinology 1998;139:1692-1699.
15. Cozzolino M, Dusso AS, Slatopolsky E: Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 2001;12:2511-2516.
16. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Mori H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000;87:E10-E17.
17. Giachelli CM: Vascular calcification: In vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003;14:S300-S304.
18. Chertow GM, Burke SK, Dillon MA, Slatopolsky E: Long-term effects of sevelamer hydrochloride on the calcium X phosphate product and lipid profile of hemodialysis patients. Nephrol Dial Transplant 1999;14:2907-2914.
19. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.
20. Hutchinson AJ: Calcitriol, lanthanum carbonate and other phosphate binders in the management of renal osteodystrophy. Perit Dial Int 1999;14:408-412.
21. Lacour B, Lucas A, Auchere D, Ruellan N, de Serre Patey NM, Drueke TB: Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration. Kidney Int 2005;67:1062-1069.
22. 2+-sensing receptor from bovine parathyroid. Nature 1993;366:575-580.
23. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993;75:1297-1303.
24. Brown AJ, Zhong M, Finch J, Ritter C, McCracken R, Morrissey J, Slatopolsky E: Rat calcium-sensing receptor is regulated by vitamin D but not calcium. Am J Physiol 1996;270:F454-F460.
25. 3. Endocrinology 1989;125:275-280.
26. Okazaki T, Zajac JD, Igarashi T, Ogata E, Kronenberg HM: Negative regulatory elements in the human parathyroid hormone gene. J Biol Chem 1991;266:21903-21910.
27. Bellorin-Font E, Martin KJ, Freitag JJ, Slatopolsky E: Altered adenylate cyclase kinetics in hyperfunctioning human parathyroid glands. J Clin Endocrinol Metab 1981;52:499-507.
28. Brown EM, Wilson RE, Thatcher JG, Marynick SP: Abnormal calcium regulated PTH release in normal parathyroid tissue from patients with adenoma. Am J Med 1981;71:565-571.
29. Kifor O, Moore FD, Wang P, Goldstein M, Vassilev P, Kifor I, Hebert SC, Brown EM: Reduced immunostaining for the extracellular Ca sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996;81:1598-1606.
30. 3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats. Kidney Int 1996;50:34-39.